Islet cell transplantation improves nerve conduction velocity in type 1 diabetes compared with intensive medical therapy over six years

Diabetes Res Clin Pract. 2016 Dec:122:101-105. doi: 10.1016/j.diabres.2016.10.011. Epub 2016 Oct 19.

Abstract

Background: Neuropathy is a common diabetic complication that can result in significant disability. Few treatment options exist to reverse this process.

Methods: We conducted a one-way crossover cohort study comparing intensive medical treatment and islet cell transplantation for type 1 diabetes on the change in nerve conduction velocity over six years.

Findings: For subjects with some neuropathy at baseline (Z score below -1), nerve conduction velocity significantly improved post-transplant (slope (0.073±0.042) while it worsened in medically treated patients (-0.136±0.081) (p<.05).

Interpretation: Islet cell transplantation improves nerve conduction velocity and could be further investigated as a treatment for neuropathy in type 1 diabetes.

Keywords: Diabetic neuropathy; Islet transplantation.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Critical Care / methods*
  • Cross-Over Studies
  • Diabetes Mellitus, Type 1 / complications*
  • Diabetes Mellitus, Type 1 / therapy
  • Diabetic Neuropathies / etiology
  • Diabetic Neuropathies / physiopathology
  • Diabetic Neuropathies / therapy*
  • Female
  • Follow-Up Studies
  • Humans
  • Islets of Langerhans Transplantation / methods*
  • Male
  • Neural Conduction / physiology*
  • Time Factors